Search results (11)
« Back to PublicationsCirculating tumor cells in myeloma are a compound biomarker for bone marrow high-risk genomic alterations and tumor load.
Journal article
Fokkema C. et al, (2025), Blood
The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy.
Journal article
Korst CLBM. et al, (2025), Blood, 145, 3007 - 3014
Bone marrow inflammation in haematological malignancies.
Journal article
de Jong MME. et al, (2024), Nat Rev Immunol, 24, 543 - 558
n IL-1β-driven neutrophil-stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma.
Journal article
de Jong MME. et al, (2024), Nat Immunol, 25, 820 - 833
n IL-1β driven neutrophil-stromal cell axis fosters a BAFF-rich microenvironment in multiple myeloma
Journal article
de Jong M. et al, (2023), BioRxiv
Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML.
Journal article
Chen L. et al, (2023), Blood Cancer Discov, 4, 394 - 417
Immune-mediated tumor control in the 5TGM1 transfer model of multiple myeloma
Preprint
Kellermayer Z. et al, (2023)
Essential role for Gata2 in modulating lineage output from hematopoietic stem cells in zebrafish.
Journal article
Gioacchino E. et al, (2021), Blood Adv, 5, 2687 - 2700
The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape.
Journal article
de Jong MME. et al, (2021), Nat Immunol, 22, 769 - 780
The presence of CLL-associated stereotypic B cell receptors in the normal BCR repertoire from healthy individuals increases with age.
Journal article
Muggen AF. et al, (2019), Immun Ageing, 16